Literature DB >> 5930900

The anticryptococcal factor of blood serum. A preliminary report.

G Szilagyi, F Reiss, J C Smith.   

Abstract

Mesh:

Substances:

Year:  1966        PMID: 5930900     DOI: 10.1038/jid.1966.47

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  7 in total

Review 1.  Cryptococcal interactions with the host immune system.

Authors:  Kerstin Voelz; Robin C May
Journal:  Eukaryot Cell       Date:  2010-04-09

2.  Phagocytosis of Cryptococcus neoformans by alveolar macrophages.

Authors:  G S Bulmer; J R Tacker
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

3.  Characterization of an anticryptococcal protein isolated from human serum.

Authors:  S Sridhar; M Ahluwalia; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

4.  Study of the role of iron in the anticryptococcal activity of human serum and fluconazole.

Authors:  D D Grover; E Brummer; D A Stevens
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

5.  Immunological studies of the anticryptococcal factor of normal human serum.

Authors:  F Reiss; G Szilagyi; E Mayer
Journal:  Mycopathologia       Date:  1975-06-14       Impact factor: 2.574

6.  Treatment of experimental murine cryptococcosis: a comparison of miconazole and amphotericin B.

Authors:  J R Graybill; L Mitchell; H B Levine
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

7.  Intracellular fate of Cryptococcus neoformans.

Authors:  J R Tacker; F Farhi; G S Bulmer
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.